If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
Metabolism promotes excellence in research by publishing high-quality original research papers, fast-tracking cutting-edge papers, research brief reports, mini-reviews, and other special articles related to all aspects of human metabolism. Work considered for publication in Metabolism includes studies in humans, animal and cellular models. Work with strong translational potential is prioritized. Metabolism will consider papers for publication in any aspect of translational and clinical metabolic research, including (but not limited to):
Christos S. Mantzoros, MD, DSc, PhD h.c. mult. is a Professor of Medicine at Harvard Medical School and adj. Professor at the Boston University School of Medicine.
Dr. Mantzoros obtained an MD and DSc from the University of Athens Medical School, a Master's in Clinical Epidemiology from Harvard School of Public Health and a Master’s in Medical Sciences from Harvard Medical School and he graduated from the Combined Harvard Training program in Endocrinology, Diabetes and Metabolism. He obtained Board certification in Internal Medicine, Endocrinology, Diabetes and Metabolism and in Clinical Nutrition. He had also served in the past as a Professor of Environmental Health at the Harvard School of Public Health.
As Editor-in-Chief of Metabolism: Clinical and Experimental, I'm happy to share great news about the journal.
Our Impact Factor has been continuously increasing over the past eleven years that I have been serving at the helm, and is now at 13.934, placing the journal amongst the top 4% of endocrinology, diabetes, and metabolism journals as indexed in Journal Citation Reports*.
This could not have happened without the dedication and expertise of the journal’s Editorial Board members as well its many reviewers and authors, to whom we are particularly thankful.
The COVID-19 pandemic presents an unprecedented health crisis to the entire world. As in many other instances, people with metabolic syndrome (obesity, hypertension, hyperlipidemia, and diabetes) are apparently paying a very high price.
Data, albeit mostly uncontrolled for potential confounding factors, are, unfortunately, showing that people with underlying metabolic conditions are at higher risk of both contracting COVID-19 and having a worse prognosis. At the same time, in such a sudden health crisis, it is not clear what the most appropriate management would be and thus most likely these patients may not be receiving the most appropriate care when hospitalized.
Metabolism is committed to playing a positive role during this crisis. We the Editors invite the submission of papers addressing this topic and remain committed to a fast-track quality process for the review of any relevant research on COVID-19 and guarantee free access to accepted papers.
Dr Sandhu received her PhD at Imperial College London and was awarded a Fulbright Scholarship for post-doctoral research at Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA. She is currently completing her Transplant Surgery Fellowship at Guy’s Hospital in London, UK.
Dr. Borges started his scientific carreer at his hometown, Cruz Alta, in the inner South of Brazil. After finishing his Masters in Brazil, he went to Lisbon to start his Ph.D in Molecular Biosciences (ITQB-NOVA | Universidade NOVA de Lisboa). He is currently working at the Assay Development team of Inflammatix.